Srinivas Ramachandran
Concepts (385)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nucleosomes | 15 | 2025 | 163 | 3.560 |
Why?
| | Histones | 12 | 2026 | 666 | 2.930 |
Why?
| | Chromatin | 11 | 2026 | 553 | 2.710 |
Why?
| | Cell-Free Nucleic Acids | 3 | 2026 | 33 | 2.230 |
Why?
| | Mycobacterium tuberculosis | 7 | 2026 | 318 | 1.990 |
Why?
| | Chromatin Assembly and Disassembly | 8 | 2025 | 108 | 1.820 |
Why?
| | Computational Biology | 10 | 2025 | 669 | 1.600 |
Why?
| | Transcription, Genetic | 12 | 2022 | 1454 | 1.460 |
Why?
| | Hydro-Lyases | 2 | 2026 | 7 | 1.440 |
Why?
| | Transcription Factors | 7 | 2022 | 1734 | 1.370 |
Why?
| | Bacterial Proteins | 9 | 2019 | 967 | 1.330 |
Why?
| | Promoter Regions, Genetic | 9 | 2025 | 1246 | 1.270 |
Why?
| | Heterochromatin | 3 | 2026 | 66 | 1.250 |
Why?
| | Antitubercular Agents | 3 | 2026 | 208 | 1.250 |
Why?
| | Software | 7 | 2026 | 680 | 1.190 |
Why?
| | Polycomb Repressive Complex 2 | 2 | 2026 | 79 | 0.980 |
Why?
| | Saccharomycetales | 2 | 2018 | 29 | 0.960 |
Why?
| | Histone Chaperones | 1 | 2025 | 15 | 0.880 |
Why?
| | Saccharomyces cerevisiae Proteins | 4 | 2025 | 414 | 0.880 |
Why?
| | G1 Phase | 1 | 2025 | 65 | 0.880 |
Why?
| | Fungi | 3 | 2017 | 121 | 0.860 |
Why?
| | Enzyme Inhibitors | 3 | 2026 | 820 | 0.850 |
Why?
| | Open Reading Frames | 1 | 2025 | 130 | 0.840 |
Why?
| | DNA Replication | 2 | 2017 | 249 | 0.840 |
Why?
| | Drosophila melanogaster | 4 | 2019 | 237 | 0.800 |
Why?
| | Psoriasis | 1 | 2025 | 115 | 0.790 |
Why?
| | Cell Cycle | 2 | 2024 | 598 | 0.760 |
Why?
| | DNA | 2 | 2022 | 1435 | 0.740 |
Why?
| | Biological Products | 1 | 2026 | 257 | 0.720 |
Why?
| | Alzheimer Disease | 9 | 2025 | 630 | 0.710 |
Why?
| | Genome, Fungal | 4 | 2017 | 44 | 0.700 |
Why?
| | Protein Binding | 8 | 2025 | 2238 | 0.680 |
Why?
| | Drug Resistance, Bacterial | 1 | 2022 | 185 | 0.670 |
Why?
| | NF-kappa B | 1 | 2025 | 666 | 0.660 |
Why?
| | Epigenomics | 2 | 2020 | 114 | 0.660 |
Why?
| | Virulence Factors | 2 | 2014 | 174 | 0.660 |
Why?
| | Mouse Embryonic Stem Cells | 3 | 2026 | 36 | 0.650 |
Why?
| | Oryza | 3 | 2020 | 32 | 0.650 |
Why?
| | High-Throughput Nucleotide Sequencing | 3 | 2026 | 530 | 0.640 |
Why?
| | Gene Expression Regulation | 5 | 2025 | 2597 | 0.640 |
Why?
| | DNA Methylation | 3 | 2022 | 674 | 0.640 |
Why?
| | Databases, Genetic | 4 | 2025 | 238 | 0.630 |
Why?
| | Anti-Infective Agents | 1 | 2022 | 232 | 0.610 |
Why?
| | Enhancer Elements, Genetic | 1 | 2021 | 191 | 0.600 |
Why?
| | Fungal Vaccines | 2 | 2017 | 2 | 0.590 |
Why?
| | RNA Polymerase II | 6 | 2022 | 350 | 0.590 |
Why?
| | Archaeal Proteins | 4 | 2007 | 50 | 0.550 |
Why?
| | Molecular Docking Simulation | 6 | 2026 | 119 | 0.540 |
Why?
| | Deoxyuridine | 1 | 2018 | 6 | 0.540 |
Why?
| | User-Computer Interface | 4 | 2025 | 165 | 0.530 |
Why?
| | Protozoan Proteins | 2 | 2008 | 90 | 0.520 |
Why?
| | Molecular Dynamics Simulation | 10 | 2026 | 265 | 0.520 |
Why?
| | Gene Regulatory Networks | 2 | 2025 | 317 | 0.510 |
Why?
| | Binding Sites | 8 | 2025 | 1310 | 0.500 |
Why?
| | Gene Expression Profiling | 9 | 2022 | 1767 | 0.490 |
Why?
| | Bridged-Ring Compounds | 1 | 2016 | 31 | 0.490 |
Why?
| | Algorithms | 6 | 2015 | 1845 | 0.480 |
Why?
| | Mycoses | 1 | 2017 | 88 | 0.470 |
Why?
| | S Phase | 1 | 2016 | 78 | 0.470 |
Why?
| | Epigenesis, Genetic | 2 | 2020 | 679 | 0.470 |
Why?
| | Ketones | 1 | 2016 | 50 | 0.470 |
Why?
| | Data Mining | 2 | 2021 | 113 | 0.470 |
Why?
| | Dinucleotide Repeats | 2 | 2007 | 6 | 0.460 |
Why?
| | Saccharomyces cerevisiae | 4 | 2025 | 573 | 0.460 |
Why?
| | Methylation | 3 | 2025 | 242 | 0.460 |
Why?
| | PubMed | 1 | 2015 | 15 | 0.460 |
Why?
| | Search Engine | 1 | 2015 | 13 | 0.460 |
Why?
| | Repetitive Sequences, Nucleic Acid | 2 | 2006 | 117 | 0.460 |
Why?
| | Fomites | 1 | 2015 | 6 | 0.450 |
Why?
| | Drug Resistance, Microbial | 1 | 2015 | 64 | 0.440 |
Why?
| | Mutation | 7 | 2025 | 4075 | 0.430 |
Why?
| | Animals | 22 | 2026 | 38030 | 0.420 |
Why?
| | Amyloid beta-Peptides | 5 | 2016 | 244 | 0.420 |
Why?
| | Micrococcal Nuclease | 3 | 2021 | 26 | 0.410 |
Why?
| | Metagenomics | 1 | 2015 | 149 | 0.410 |
Why?
| | Sequence Analysis, Protein | 2 | 2004 | 32 | 0.400 |
Why?
| | Superoxide Dismutase-1 | 3 | 2018 | 13 | 0.400 |
Why?
| | Sequence Analysis, DNA | 5 | 2026 | 777 | 0.390 |
Why?
| | Adhesins, Bacterial | 3 | 2014 | 44 | 0.380 |
Why?
| | Plasmodium | 2 | 2014 | 12 | 0.370 |
Why?
| | Phenotype | 2 | 2020 | 3155 | 0.370 |
Why?
| | Amyotrophic Lateral Sclerosis | 3 | 2018 | 95 | 0.360 |
Why?
| | Drug Evaluation, Preclinical | 2 | 2026 | 196 | 0.360 |
Why?
| | Humans | 49 | 2026 | 145475 | 0.360 |
Why?
| | Malaria | 2 | 2014 | 72 | 0.360 |
Why?
| | Acyltransferases | 1 | 2012 | 78 | 0.360 |
Why?
| | Workflow | 2 | 2025 | 183 | 0.360 |
Why?
| | Antigens, Bacterial | 1 | 2012 | 126 | 0.340 |
Why?
| | Gene Expression Regulation, Fungal | 2 | 2025 | 78 | 0.340 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2013 | 337 | 0.330 |
Why?
| | Breast Neoplasms | 3 | 2025 | 2382 | 0.330 |
Why?
| | Gene Expression | 3 | 2020 | 1476 | 0.330 |
Why?
| | Proteomics | 2 | 2011 | 1188 | 0.330 |
Why?
| | Databases, Protein | 1 | 2011 | 88 | 0.330 |
Why?
| | Genome, Human | 4 | 2007 | 420 | 0.320 |
Why?
| | Fungal Proteins | 1 | 2011 | 143 | 0.320 |
Why?
| | Peptide Fragments | 5 | 2016 | 693 | 0.310 |
Why?
| | Proteome | 2 | 2006 | 514 | 0.310 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2025 | 2588 | 0.310 |
Why?
| | Amyloid beta-Protein Precursor | 2 | 2025 | 64 | 0.310 |
Why?
| | Estrogen Receptor alpha | 2 | 2025 | 151 | 0.300 |
Why?
| | Genomics | 3 | 2018 | 825 | 0.290 |
Why?
| | Biomarkers | 1 | 2020 | 4295 | 0.290 |
Why?
| | Malaria Vaccines | 1 | 2008 | 11 | 0.280 |
Why?
| | Lysine | 2 | 2025 | 305 | 0.280 |
Why?
| | Hydrogen Bonding | 4 | 2018 | 169 | 0.270 |
Why?
| | Epilepsy | 2 | 2025 | 390 | 0.270 |
Why?
| | Multigene Family | 2 | 2006 | 210 | 0.270 |
Why?
| | Polycomb-Group Proteins | 2 | 2026 | 36 | 0.260 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2020 | 139 | 0.260 |
Why?
| | Microbiota | 1 | 2015 | 730 | 0.260 |
Why?
| | Base Composition | 2 | 2006 | 82 | 0.260 |
Why?
| | Genetic Predisposition to Disease | 3 | 2025 | 2378 | 0.260 |
Why?
| | Cell Differentiation | 2 | 2025 | 2046 | 0.250 |
Why?
| | Prokaryotic Cells | 1 | 2006 | 6 | 0.240 |
Why?
| | Polymorphism, Genetic | 2 | 2006 | 614 | 0.240 |
Why?
| | Introns | 1 | 2007 | 255 | 0.240 |
Why?
| | Drosophila | 3 | 2021 | 164 | 0.230 |
Why?
| | Metadata | 1 | 2026 | 17 | 0.230 |
Why?
| | Cyclins | 1 | 2006 | 79 | 0.230 |
Why?
| | Genome, Plant | 3 | 2011 | 36 | 0.230 |
Why?
| | Evolution, Molecular | 2 | 2018 | 492 | 0.230 |
Why?
| | Databases, Factual | 2 | 2026 | 1490 | 0.220 |
Why?
| | Presenilin-2 | 1 | 2025 | 6 | 0.220 |
Why?
| | Cell Line | 3 | 2021 | 2823 | 0.220 |
Why?
| | Presenilin-1 | 1 | 2025 | 34 | 0.220 |
Why?
| | Protein Domains | 2 | 2024 | 311 | 0.220 |
Why?
| | India | 4 | 2025 | 213 | 0.210 |
Why?
| | HEK293 Cells | 2 | 2025 | 741 | 0.210 |
Why?
| | Sequence Alignment | 2 | 2004 | 362 | 0.210 |
Why?
| | Germ Cells | 1 | 2024 | 65 | 0.210 |
Why?
| | Enhancer of Zeste Homolog 2 Protein | 1 | 2024 | 55 | 0.210 |
Why?
| | Embryonic Stem Cells | 1 | 2025 | 124 | 0.210 |
Why?
| | DNA-Binding Proteins | 4 | 2022 | 1480 | 0.200 |
Why?
| | Protein Conformation | 5 | 2018 | 938 | 0.200 |
Why?
| | Phylogeny | 2 | 2011 | 917 | 0.190 |
Why?
| | Bacteria | 2 | 2022 | 765 | 0.190 |
Why?
| | Models, Biological | 5 | 2018 | 1764 | 0.190 |
Why?
| | Hepatocyte Nuclear Factor 3-alpha | 1 | 2022 | 9 | 0.190 |
Why?
| | Knowledge Bases | 1 | 2022 | 28 | 0.180 |
Why?
| | Transcriptional Elongation Factors | 1 | 2022 | 39 | 0.180 |
Why?
| | Gene Duplication | 3 | 2007 | 66 | 0.180 |
Why?
| | Internet | 4 | 2026 | 689 | 0.180 |
Why?
| | Drug Discovery | 2 | 2013 | 153 | 0.180 |
Why?
| | Methanococcus | 1 | 2002 | 10 | 0.180 |
Why?
| | Mice | 5 | 2026 | 18329 | 0.180 |
Why?
| | Protein Processing, Post-Translational | 1 | 2024 | 471 | 0.170 |
Why?
| | Sorghum | 2 | 2011 | 3 | 0.170 |
Why?
| | Haemophilus influenzae | 1 | 2002 | 67 | 0.170 |
Why?
| | Estradiol | 1 | 2025 | 515 | 0.170 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2024 | 409 | 0.170 |
Why?
| | Membrane Proteins | 1 | 2007 | 1164 | 0.170 |
Why?
| | Arabs | 1 | 2021 | 10 | 0.170 |
Why?
| | Protein Interaction Maps | 1 | 2021 | 51 | 0.160 |
Why?
| | Altitude Sickness | 1 | 2022 | 141 | 0.160 |
Why?
| | Amyloid | 4 | 2016 | 94 | 0.160 |
Why?
| | Cyclin-Dependent Kinase 9 | 1 | 2020 | 18 | 0.160 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2023 | 273 | 0.160 |
Why?
| | Histone Demethylases | 1 | 2020 | 38 | 0.160 |
Why?
| | Models, Molecular | 5 | 2018 | 1598 | 0.160 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2020 | 977 | 0.160 |
Why?
| | Lipid Bilayers | 3 | 2016 | 103 | 0.160 |
Why?
| | Peptide Synthases | 1 | 2019 | 4 | 0.150 |
Why?
| | Receptors, Estrogen | 1 | 2022 | 401 | 0.150 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2020 | 161 | 0.150 |
Why?
| | Transcriptional Activation | 1 | 2021 | 372 | 0.140 |
Why?
| | Alleles | 2 | 2021 | 894 | 0.140 |
Why?
| | Biomarkers, Tumor | 1 | 2026 | 1321 | 0.140 |
Why?
| | Plasmodium yoelii | 2 | 2008 | 7 | 0.140 |
Why?
| | Genome | 1 | 2021 | 305 | 0.140 |
Why?
| | Plasmodium vivax | 2 | 2008 | 6 | 0.140 |
Why?
| | Small Molecule Libraries | 1 | 2019 | 111 | 0.140 |
Why?
| | Biosensing Techniques | 1 | 2020 | 142 | 0.140 |
Why?
| | Plasmodium falciparum | 2 | 2008 | 37 | 0.140 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 3 | 2018 | 192 | 0.140 |
Why?
| | Genome-Wide Association Study | 1 | 2025 | 1407 | 0.140 |
Why?
| | Chromosome Mapping | 3 | 2011 | 506 | 0.130 |
Why?
| | Transcription Initiation Site | 1 | 2017 | 43 | 0.130 |
Why?
| | TATA-Box Binding Protein | 1 | 2017 | 20 | 0.130 |
Why?
| | Quantitative Trait Loci | 1 | 2020 | 378 | 0.130 |
Why?
| | Amino Acid Sequence | 5 | 2016 | 2129 | 0.130 |
Why?
| | Oligopeptides | 1 | 2019 | 267 | 0.130 |
Why?
| | Pharmaceutical Preparations | 1 | 2019 | 170 | 0.130 |
Why?
| | Fluorescent Dyes | 1 | 2019 | 333 | 0.130 |
Why?
| | Click Chemistry | 1 | 2018 | 54 | 0.130 |
Why?
| | Genetic Variation | 3 | 2021 | 972 | 0.130 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 2017 | 20 | 0.130 |
Why?
| | Antigens, Fungal | 1 | 2017 | 28 | 0.120 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 363 | 0.120 |
Why?
| | Structure-Activity Relationship | 4 | 2018 | 563 | 0.120 |
Why?
| | Glioblastoma | 1 | 2020 | 353 | 0.120 |
Why?
| | Inhibitory Concentration 50 | 1 | 2016 | 90 | 0.120 |
Why?
| | Eukaryota | 1 | 2017 | 56 | 0.120 |
Why?
| | Pyruvic Acid | 1 | 2016 | 51 | 0.120 |
Why?
| | Aspartic Acid | 1 | 2016 | 88 | 0.120 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2022 | 1443 | 0.120 |
Why?
| | Disease Management | 1 | 2020 | 653 | 0.120 |
Why?
| | SELEX Aptamer Technique | 1 | 2016 | 16 | 0.120 |
Why?
| | Gene Expression Regulation, Plant | 3 | 2020 | 54 | 0.120 |
Why?
| | Tuberculosis | 1 | 2019 | 283 | 0.120 |
Why?
| | Medical Subject Headings | 1 | 2015 | 3 | 0.120 |
Why?
| | Neoplasms | 2 | 2026 | 2906 | 0.120 |
Why?
| | Response Elements | 1 | 2016 | 86 | 0.110 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2017 | 174 | 0.110 |
Why?
| | Drosophila Proteins | 1 | 2017 | 213 | 0.110 |
Why?
| | Catalytic Domain | 1 | 2016 | 234 | 0.110 |
Why?
| | Phenylalanine | 1 | 2015 | 69 | 0.110 |
Why?
| | Trichophyton | 1 | 2015 | 1 | 0.110 |
Why?
| | Onychomycosis | 1 | 2015 | 3 | 0.110 |
Why?
| | Ion Channels | 1 | 2016 | 129 | 0.110 |
Why?
| | tau Proteins | 1 | 2016 | 105 | 0.110 |
Why?
| | Aptamers, Nucleotide | 1 | 2016 | 87 | 0.110 |
Why?
| | Trans-Activators | 1 | 2017 | 396 | 0.110 |
Why?
| | Crystallography, X-Ray | 1 | 2016 | 486 | 0.110 |
Why?
| | Prognosis | 2 | 2020 | 4316 | 0.110 |
Why?
| | Enzyme Activation | 1 | 2016 | 762 | 0.110 |
Why?
| | Genome, Archaeal | 2 | 2006 | 12 | 0.110 |
Why?
| | Recombinant Proteins | 2 | 2016 | 1368 | 0.100 |
Why?
| | Metabolomics | 1 | 2020 | 732 | 0.100 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2007 | 749 | 0.100 |
Why?
| | DNA, Fungal | 1 | 2014 | 76 | 0.100 |
Why?
| | Antibiotics, Antitubercular | 1 | 2013 | 35 | 0.100 |
Why?
| | Microtubules | 1 | 2016 | 265 | 0.100 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2014 | 62 | 0.100 |
Why?
| | Centromere | 1 | 2014 | 61 | 0.100 |
Why?
| | Allergens | 1 | 2017 | 386 | 0.100 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2025 | 2158 | 0.100 |
Why?
| | Carrier Proteins | 1 | 2017 | 728 | 0.100 |
Why?
| | Genome, Bacterial | 2 | 2006 | 123 | 0.100 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2014 | 130 | 0.100 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2004 | 387 | 0.100 |
Why?
| | Sequence Deletion | 1 | 2013 | 190 | 0.100 |
Why?
| | Kinetics | 1 | 2016 | 1567 | 0.100 |
Why?
| | MicroRNAs | 1 | 2019 | 686 | 0.090 |
Why?
| | Metabolic Networks and Pathways | 1 | 2013 | 174 | 0.090 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 333 | 0.090 |
Why?
| | Cluster Analysis | 1 | 2013 | 500 | 0.090 |
Why?
| | Edible Grain | 1 | 2011 | 47 | 0.090 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1923 | 0.090 |
Why?
| | Drug Design | 1 | 2012 | 175 | 0.080 |
Why?
| | Signal Transduction | 1 | 2025 | 5216 | 0.080 |
Why?
| | Phosphorylation | 3 | 2022 | 1707 | 0.080 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2011 | 43 | 0.080 |
Why?
| | Reproducibility of Results | 3 | 2018 | 3413 | 0.080 |
Why?
| | Protein Structure, Secondary | 3 | 2018 | 371 | 0.080 |
Why?
| | Host-Pathogen Interactions | 1 | 2014 | 361 | 0.080 |
Why?
| | Brain Neoplasms | 1 | 2020 | 1329 | 0.080 |
Why?
| | Comorbidity | 1 | 2015 | 1661 | 0.080 |
Why?
| | Molecular Sequence Data | 4 | 2015 | 2883 | 0.080 |
Why?
| | Ligands | 1 | 2012 | 665 | 0.080 |
Why?
| | Cells, Cultured | 1 | 2017 | 4148 | 0.080 |
Why?
| | Genotype | 3 | 2025 | 1852 | 0.070 |
Why?
| | Computer Simulation | 1 | 2013 | 1003 | 0.070 |
Why?
| | ROC Curve | 1 | 2011 | 617 | 0.070 |
Why?
| | Amino Acids | 2 | 2018 | 519 | 0.070 |
Why?
| | Base Sequence | 4 | 2016 | 2170 | 0.070 |
Why?
| | Archaeoglobus fulgidus | 1 | 2007 | 1 | 0.070 |
Why?
| | Mycobacterium leprae | 1 | 2007 | 9 | 0.070 |
Why?
| | Antigens, Surface | 1 | 2008 | 155 | 0.070 |
Why?
| | Escherichia coli K12 | 1 | 2007 | 7 | 0.070 |
Why?
| | Protein Structure, Tertiary | 2 | 2010 | 855 | 0.070 |
Why?
| | Mycobacterium bovis | 1 | 2007 | 15 | 0.070 |
Why?
| | Expressed Sequence Tags | 1 | 2007 | 43 | 0.060 |
Why?
| | Protein Array Analysis | 1 | 2007 | 56 | 0.060 |
Why?
| | Bacillus subtilis | 1 | 2007 | 65 | 0.060 |
Why?
| | DNA Primers | 1 | 2007 | 505 | 0.060 |
Why?
| | Diabetes Mellitus | 1 | 2015 | 1097 | 0.060 |
Why?
| | Base Pairing | 1 | 2006 | 65 | 0.060 |
Why?
| | Disasters | 1 | 2007 | 100 | 0.060 |
Why?
| | Microsatellite Repeats | 1 | 2007 | 157 | 0.060 |
Why?
| | Chromosomes, Artificial, Bacterial | 1 | 2006 | 21 | 0.060 |
Why?
| | Female | 7 | 2025 | 78845 | 0.060 |
Why?
| | DNA Copy Number Variations | 2 | 2020 | 184 | 0.060 |
Why?
| | Genetic Markers | 2 | 2020 | 335 | 0.060 |
Why?
| | Single Molecule Imaging | 1 | 2026 | 45 | 0.060 |
Why?
| | Ribosomes | 1 | 2007 | 193 | 0.060 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2026 | 66 | 0.060 |
Why?
| | Escherichia coli Proteins | 1 | 2007 | 201 | 0.060 |
Why?
| | Pan troglodytes | 1 | 2005 | 62 | 0.050 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2026 | 147 | 0.050 |
Why?
| | Arabidopsis Proteins | 1 | 2006 | 76 | 0.050 |
Why?
| | STAT1 Transcription Factor | 1 | 2025 | 66 | 0.050 |
Why?
| | Neurons | 2 | 2025 | 1649 | 0.050 |
Why?
| | MCF-7 Cells | 1 | 2025 | 133 | 0.050 |
Why?
| | Models, Genetic | 1 | 2007 | 524 | 0.050 |
Why?
| | Glycolysis | 1 | 2006 | 340 | 0.050 |
Why?
| | CD28 Antigens | 1 | 2024 | 59 | 0.050 |
Why?
| | Models, Theoretical | 1 | 2008 | 558 | 0.050 |
Why?
| | Twins, Monozygotic | 1 | 2005 | 133 | 0.050 |
Why?
| | Databases, Nucleic Acid | 1 | 2003 | 38 | 0.050 |
Why?
| | Models, Statistical | 2 | 2005 | 671 | 0.050 |
Why?
| | Models, Chemical | 1 | 2004 | 250 | 0.050 |
Why?
| | Down Syndrome | 1 | 2010 | 525 | 0.050 |
Why?
| | Campylobacter jejuni | 1 | 2003 | 16 | 0.050 |
Why?
| | Vibrio cholerae | 1 | 2003 | 14 | 0.050 |
Why?
| | Strongyloides stercoralis | 1 | 2002 | 2 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2004 | 397 | 0.050 |
Why?
| | Antigens, Helminth | 1 | 2002 | 16 | 0.050 |
Why?
| | Strongyloidiasis | 1 | 2002 | 4 | 0.050 |
Why?
| | Peptide Elongation Factors | 1 | 2022 | 15 | 0.050 |
Why?
| | Microscopy, Atomic Force | 2 | 2016 | 128 | 0.050 |
Why?
| | Helicobacter pylori | 1 | 2003 | 44 | 0.050 |
Why?
| | Erythropoiesis | 1 | 2022 | 57 | 0.040 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 3542 | 0.040 |
Why?
| | Familial Mediterranean Fever | 1 | 2021 | 7 | 0.040 |
Why?
| | Hemoglobinopathies | 1 | 2021 | 6 | 0.040 |
Why?
| | Protease Inhibitors | 1 | 2021 | 102 | 0.040 |
Why?
| | Risk Factors | 1 | 2015 | 10885 | 0.040 |
Why?
| | Epilepsy, Absence | 1 | 2020 | 12 | 0.040 |
Why?
| | Age of Onset | 1 | 2022 | 555 | 0.040 |
Why?
| | Epilepsy, Generalized | 1 | 2020 | 24 | 0.040 |
Why?
| | Positive Transcriptional Elongation Factor B | 1 | 2020 | 29 | 0.040 |
Why?
| | Gibberellins | 1 | 2020 | 1 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2015 | 11772 | 0.040 |
Why?
| | Pharmacogenomic Testing | 1 | 2020 | 63 | 0.040 |
Why?
| | Plant Breeding | 1 | 2020 | 20 | 0.040 |
Why?
| | Gene Frequency | 1 | 2021 | 487 | 0.040 |
Why?
| | Plant Proteins | 1 | 2020 | 111 | 0.040 |
Why?
| | Molecular Conformation | 1 | 2019 | 141 | 0.040 |
Why?
| | Color | 1 | 2019 | 81 | 0.040 |
Why?
| | Drug Repositioning | 1 | 2019 | 39 | 0.040 |
Why?
| | Fluorescence | 1 | 2019 | 159 | 0.040 |
Why?
| | Enzyme Stability | 1 | 2018 | 73 | 0.040 |
Why?
| | Escherichia coli | 1 | 2003 | 835 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2019 | 302 | 0.030 |
Why?
| | Autoimmunity | 1 | 2024 | 933 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2019 | 204 | 0.030 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2022 | 534 | 0.030 |
Why?
| | Molecular Structure | 1 | 2019 | 486 | 0.030 |
Why?
| | Microscopy, Fluorescence | 1 | 2019 | 408 | 0.030 |
Why?
| | TATA-Binding Protein Associated Factors | 1 | 2017 | 21 | 0.030 |
Why?
| | Genes | 1 | 2018 | 227 | 0.030 |
Why?
| | Transcription Factor TFIID | 1 | 2017 | 21 | 0.030 |
Why?
| | RNA, Fungal | 1 | 2017 | 67 | 0.030 |
Why?
| | Conserved Sequence | 1 | 2018 | 244 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2020 | 627 | 0.030 |
Why?
| | Protein Subunits | 1 | 2017 | 229 | 0.030 |
Why?
| | Seizures | 1 | 2020 | 483 | 0.030 |
Why?
| | Inverted Repeat Sequences | 1 | 2016 | 18 | 0.030 |
Why?
| | Precision Medicine | 1 | 2020 | 459 | 0.030 |
Why?
| | Regression Analysis | 1 | 2018 | 1001 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1808 | 0.030 |
Why?
| | Transcriptome | 1 | 2022 | 1038 | 0.030 |
Why?
| | Gene Deletion | 1 | 2017 | 391 | 0.030 |
Why?
| | Dimerization | 1 | 2016 | 189 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2021 | 769 | 0.030 |
Why?
| | Arthrodermataceae | 1 | 2015 | 2 | 0.030 |
Why?
| | Family Health | 1 | 2015 | 191 | 0.030 |
Why?
| | Hypoxia | 1 | 2022 | 1199 | 0.030 |
Why?
| | Survival Analysis | 1 | 2018 | 1374 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2024 | 5983 | 0.020 |
Why?
| | Cytoplasm | 1 | 2014 | 254 | 0.020 |
Why?
| | Transgenes | 1 | 2014 | 190 | 0.020 |
Why?
| | Estrogens | 1 | 2016 | 367 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2016 | 730 | 0.020 |
Why?
| | Phosphatidylcholines | 1 | 2013 | 130 | 0.020 |
Why?
| | Genetic Testing | 1 | 2015 | 480 | 0.020 |
Why?
| | RNA Interference | 1 | 2014 | 475 | 0.020 |
Why?
| | INDEL Mutation | 1 | 2011 | 22 | 0.020 |
Why?
| | Male | 4 | 2025 | 72843 | 0.020 |
Why?
| | Disease Resistance | 1 | 2011 | 29 | 0.020 |
Why?
| | Breeding | 1 | 2011 | 63 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 2014 | 723 | 0.020 |
Why?
| | Peptides | 1 | 2016 | 998 | 0.020 |
Why?
| | Brain | 1 | 2022 | 2947 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 7123 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2017 | 2803 | 0.020 |
Why?
| | Aged | 2 | 2022 | 26153 | 0.020 |
Why?
| | Middle Aged | 2 | 2025 | 36215 | 0.020 |
Why?
| | Cell Death | 1 | 2010 | 382 | 0.020 |
Why?
| | United States | 1 | 2026 | 16098 | 0.020 |
Why?
| | Rats | 1 | 2016 | 5584 | 0.020 |
Why?
| | RNA | 1 | 2014 | 910 | 0.020 |
Why?
| | DNA, Complementary | 1 | 2005 | 273 | 0.010 |
Why?
| | Oligonucleotides | 1 | 2005 | 153 | 0.010 |
Why?
| | Calcium | 1 | 2010 | 1190 | 0.010 |
Why?
| | Leukocytes | 1 | 2005 | 296 | 0.010 |
Why?
| | Haplotypes | 1 | 2005 | 499 | 0.010 |
Why?
| | Histamine | 1 | 2002 | 52 | 0.010 |
Why?
| | Life Cycle Stages | 1 | 2002 | 37 | 0.010 |
Why?
| | Cross Reactions | 1 | 2002 | 130 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2002 | 538 | 0.010 |
Why?
| | Blotting, Western | 1 | 2002 | 1179 | 0.010 |
Why?
| | Sex Factors | 1 | 2005 | 2105 | 0.010 |
Why?
| | Adult | 1 | 2005 | 40777 | 0.000 |
Why?
|
|
Ramachandran's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|